{"url_path":"/sec/inmb/8-k/2026-07-01/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial statements and Exhibits**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-01","source_url":"https://www.sec.gov/Archives/edgar/data/1711754/0001213900-26-073983-index.html","accession_number":"0001213900-26-073983","cik":"0001711754","ticker":"INMB","issuer_name":"Inmune Bio, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1711754/0001213900-26-073983-index.html","primary_entity_key":"0001711754","primary_entity_name":"Inmune Bio, Inc."},"word_count":85,"has_tables":true,"body_markdown":"**Item 9.01 Financial statements and Exhibits**\n\n \n\n(d) Exhibits.\n\n \n\n4.1\n \n[Form of Amendment to Common Stock Purchase Warrant](ea029662401ex4-1.htm)\n\n10.1\n \n[Form of Inducement Letter](ea029662401ex10-1.htm)\n\n104\n \nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n \n\n1\n\n \n\n \n\n**SIGNATURES**\n\n** **\n\nPursuant to the requirements of the Securities\nExchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n**INMUNE BIO INC.**\n\n \n \n\nDate: July 1, 2026\nBy:\n*/s/ David Moss*\n\n \nName:\nDavid Moss\n\n \nTitle:\nChief Executive Officer\n\n \n\n2"}